Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Crinetics Pharmaceuticals
CRNX
$8.87B
| $8.23M | ﹤0.01% |
289,735
+66,488
| +30% | +$1.64M |
|
2102
Cass Information Systems
CASS
$723M
| $8.23M | ﹤0.01% |
209,250
+4,780
| +2% | +$203K |
|
2103
Hawkins
HWKN
$2.78B
| $8.23M | ﹤0.01% |
208,569
+24,030
| +13% | +$889K |
|
|
WW
2104
DELISTED
WW International
WW
| $8.23M | ﹤0.01% |
510,047
+31,257
| +7% | +$561K |
|
2105
Harmonic Inc
HLIT
$1.27B
| $8.22M | ﹤0.01% |
699,295
+19,757
| +3% | +$204K |
|
2106
XPEL
XPEL
$1.21B
| $8.16M | ﹤0.01% |
119,509
+2,322
| +2% | +$167K |
|
2107
American Well
AMWL
$183M
| $8.16M | ﹤0.01% |
67,520
+4,629
| +7% | +$706K |
|
2108
SelectQuote
SLQT
$135M
| $8.14M | ﹤0.01% |
898,205
+13,645
| +2% | +$150K |
|
2109
Unitil
UTL
$966M
| $8.11M | ﹤0.01% |
176,401
+6,370
| +4% | +$276K |
|
2110
Hayward Holdings
HAYW
$3.28B
| $8.08M | ﹤0.01% |
308,169
+9,007
| +3% | +$218K |
|
2111
Manitowoc
MTW
$515M
| $8.07M | ﹤0.01% |
434,292
+10,769
| +3% | +$218K |
|
2112
PC Connection
CNXN
$2.17B
| $8.07M | ﹤0.01% |
187,158
+10,075
| +6% | +$456K |
|
|
INFA
2113
DELISTED
Informatica
INFA
| $8.07M | ﹤0.01% |
+218,266
| New | +$7.38M |
|
2114
BrightView Holdings
BV
$1.26B
| $8.07M | ﹤0.01% |
573,064
+82,907
| +17% | +$1.25M |
|
|
SLGC
2115
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $8.06M | ﹤0.01% |
+692,275
| New | +$8.29M |
|
2116
Lemonade
LMND
$4.13B
| $8.06M | ﹤0.01% |
191,306
+3,899
| +2% | +$219K |
|
2117
Allogene Therapeutics
ALLO
$632M
| $8.01M | ﹤0.01% |
537,045
+6,049
| +1% | +$107K |
|
2118
Yext
YEXT
$568M
| $7.99M | ﹤0.01% |
805,435
+17,774
| +2% | +$200K |
|
2119
WisdomTree
WT
$3.23B
| $7.99M | ﹤0.01% |
1,305,008
-7,006
| -0.5% | -$43.4K |
|
|
TRTX
2120
TPG RE Finance Trust
TRTX
$623M
| $7.98M | ﹤0.01% |
647,989
+74,869
| +13% | +$953K |
|
2121
iShares MSCI EAFE ETF
EFA
$78.4B
| $7.97M | ﹤0.01% |
101,351
+65,021
| +179% | +$5.15M |
|
|
SLCA
2122
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $7.95M | ﹤0.01% |
845,665
-100,021
| -11% | -$997K |
|
|
PTRA
2123
DELISTED
Proterra Inc. Common Stock
PTRA
| $7.93M | ﹤0.01% |
898,543
+37,466
| +4% | +$384K |
|
2124
LeMaitre Vascular
LMAT
$2.37B
| $7.93M | ﹤0.01% |
157,799
+1,756
| +1% | +$90.8K |
|
|
CANO
2125
DELISTED
Cano Health, Inc.
CANO
| $7.91M | ﹤0.01% |
8,877
+855
| +11% | +$898K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.